AEON Biopharma Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

10.56M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	2.52M	-839.00K	-24.99%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	64.24B
AbbVie	59.64B
Eli Lilly and Company	59.42B
AstraZeneca	58.13B
Novartis AG	56.37B
Novo Nordisk	49.58B

Revenue Rankings

AEON News

5 weeks ago - AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 - GlobeNewsWire
3 months ago - AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
6 months ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
6 months ago - AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - GlobeNewsWire
6 months ago - AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
7 months ago - AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - GlobeNewsWire
7 months ago - AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - GlobeNewsWire
8 months ago - AEON Biopharma Announces CEO Transition - GlobeNewsWire

More News